Resistance Training Program and Cardiovascular Exercise in Increasing Muscle Mass in Adolescent and Young Adult Stem Cell Transplant Survivors
Completed · Not applicable
Conditions studied: Malignant Neoplasm
In brief
This pilot trial studies how well a resistance training program and cardiovascular exercise work in increasing muscle mass in adolescent and young adult stem cell transplant survivors. Resistance training and cardiovascular exercise may increase physical activity, muscular strength and improve lean body mass which is beneficial to improving the overall health of stem cell transplant survivors.
Key facts
- Study ID
- NCT03672981
- Run by
- Fred Hutchinson Cancer Center
- People needed
- 20
- Starts
- 2018-11-21
- Expected to finish
- 2020-10-31
- Last updated by the study team
- 2020-11-16
Who can join
Age: 13 and older, up to 39. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- > 80 days but less than <120 days post-autologous or allogeneic HCT for a malignancy.
- Platelet transfusion independent.
- Fully mobile on an independent basis.
- For patients who have been on steroid therapy for graft versus (vs) host disease, doses of prednisone must be =< 1.0 mg/kg/day and they must be on a tapering schedule.
- English speaking.
You may not qualify if…
- Individuals who are determined by the investigators or primary treating physician to not be physically able to participate in an independent exercise intervention such as hospitalized, wheel chair bound, unable to ambulate independently, on oxygen.
- Women who are pregnant will be excluded.
Where it is running
- Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.